PEAK6 Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$35.8M Buy
450,700
+56,700
+14% +$4.71M 0.15% 104
2018
Q1
$35.1M Buy
394,000
+74,300
+23% +$7.13M 0.15% 105
2017
Q4
$33.4M Buy
319,700
+264,400
+478% +$29.8M 0.16% 121
2017
Q3
$8.06M Buy
55,300
+29,700
+116% +$4.05M 0.04% 514
2017
Q2
$3.33M Sell
25,600
-196,800
-88% -$24.1M 0.02% 970
2017
Q1
$27.7M Sell
222,400
-264,700
-54% -$31.7M 0.23% 67
2016
Q4
$56.4M Buy
487,100
+180,800
+59% +$20.1M 0.4% 14
2016
Q3
$32M Buy
306,300
+44,000
+17% +$4.76M 0.24% 55
2016
Q2
$25.9M Buy
262,300
+130,900
+100% +$13.5M 0.2% 80
2016
Q1
$13.2M Sell
131,400
-153,500
-54% -$15.8M 0.11% 229
2015
Q4
$34.1M Sell
284,900
-122,000
-30% -$14.1M 0.23% 54
2015
Q3
$44M Buy
406,900
+56,900
+16% +$7.06M 0.23% 57
2015
Q2
$40.5M Sell
350,000
-35,800
-9% -$4.09M 0.24% 48
2015
Q1
$44.5M Buy
385,800
+101,800
+36% +$12.2M 0.34% 22
2014
Q4
$31.8M Buy
284,000
+6,100
+2% +$643K 0.24% 55
2014
Q3
$26.3M Sell
277,900
-54,800
-16% -$4.95M 0.2% 81
2014
Q2
$28.6M Sell
332,700
-115,700
-26% -$8.8M 0.27% 41
2014
Q1
$31.3M Buy
448,400
+371,000
+479% +$29.4M 0.27% 33
2013
Q4
$6.54M Sell
77,400
-279,000
-78% -$22.1M 0.05% 558
2013
Q3
$13.7M Buy
356,400
+204,200
+134% +$14.3M 0.09% 202
2013
Q2
$8.9K Buy
+152,200
New +$9.16M 0.03% 376

Other funds holding CELG

PEAK6 Group's CELG Position: Q2 2018 in Review

PEAK6 Group reduced its Celgene Corp (CELG) stake by 40% in Q2 2018, selling an estimated $6.04M and leaving 109,584 shares worth $8.7M. The position accounts for 0.04% of the portfolio, ranked #512.

PEAK6 Group first reported a position in CELG in Q4 2013 and has held it in 16 quarters since. The position peaked at $34M in Q2 2015. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • PEAK6 Group held 109,584 shares of Celgene Corp worth $8.7M as of Q2 2018.
  • PEAK6 Group sold 72,740 Celgene Corp shares in Q2 2018, an estimated $6.04M.
  • Celgene Corp made up 0.04% of PEAK6 Group's portfolio in Q2 2018, its #512 holding.
  • PEAK6 Group first reported a position in Celgene Corp in Q4 2013 and has held it in 16 quarters since.
  • PEAK6 Group's Celgene Corp position peaked at $34M in Q2 2015.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.